Optometry in Practice (OiP), the College's quarterly CPD journal, covers the latest research, analysis and opinion from your profession, and provides up to 4 CPD points.
Current imaging-based technologies which can aid the detection of ACG.
Introduction
Angle closure glaucoma (ACG) is a major cause of visual morbidity worldwide (Quigley and Broman 2006). With the ageing population and increasing longevity, the World Health Organization (WHO) estimates that 11.2 million people will be bilaterally blind from glaucoma worldwide by the year 2020, and nearly half of these cases will be the result of ACG (WHO 2007). The first article in this series (Dabasia et al. 2013a) considered the definitions/classification, epidemiology and risk factors for ACG. The second paper (Dabasia et al. 2013b) presented a review of traditional slit-lamp techniques to screen for the condition. This final article will review current imaging-based technologies which can aid the detection of ACG.
Sign in to continue
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Pressure on optometrists to treat glaucoma is likely to grow as case numbers are predicted to rise 44% by 2035. Beta blockers will remain a part of the fight ahead, as Adrian O’Dowd reports.
Sometimes, progress is made not by inventing something new, but by looking at something that’s been around for a long time in a new way, says Kieran Loft.